AI Assurance Lab Concept Leaves Potential Regulatory Gap

 
• By Derrick Gingery
AI in drug development
The FDA is investing in AI lifecycle management, Tazbaz said. • Source: Shutterstock

More from AI

More from Advanced Technologies